{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:15Z","timestamp":1790716935733,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An estimated 2.4 million people in the United States are living with hepatitis C virus (HCV) infection. In 2020, the Centers for Disease Control and Prevention updated hepatitis C screening recommendations to test adults aged \u226518 years at least once in a lifetime and pregnant persons during each pregnancy. For those with ongoing exposure to HCV, periodic testing is recommended. The recommended testing sequence is to obtain an HCV antibody test and, when positive, perform an HCV RNA test. Examination of HCV care cascades has found that incomplete HCV testing occurs when a separate visit is required to obtain the HCV RNA test. Hepatitis C core antigen testing has been shown to be a useful tool for diagnosing current HCV infection in some settings. Hepatitis C testing that is completed, accurate, and efficient is necessary to achieve hepatitis C elimination goals.<\/jats:p>","DOI":"10.1093\/infdis\/jiad199","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T01:18:02Z","timestamp":1695431882000},"page":"S350-S356","source":"Crossref","is-referenced-by-count":7,"title":["Opportunities for Enhanced Prevention and Control of Hepatitis C Through Improved Screening and Testing Efforts"],"prefix":"10.1093","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2954-5106","authenticated-orcid":false,"given":"Emily J","family":"Cartwright","sequence":"first","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention"},{"name":"Medicine, Emory University , Atlanta"},{"name":"Infectious Diseases Section, Atlanta Veterans Affairs Health Care System , Decatur , Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti R","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"2024050816260220100_jiad199-B1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"2024050816260220100_jiad199-B2","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2024050816260220100_jiad199-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2024050816260220100_jiad199-B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2016.05.030","article-title":"Sexually acquired hepatitis C virus infection: a review","volume":"49","author":"Chan","year":"2016","journal-title":"Int J Infect Dis"},{"key":"2024050816260220100_jiad199-B5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/hep.25688","article-title":"Case-control study of hepatitis B and hepatitis C in older adults: do healthcare exposures contribute to burden of new infections?","volume":"57","author":"Perz","year":"2013","journal-title":"Hepatology"},{"key":"2024050816260220100_jiad199-B6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/MLR.0b013e31825517d4","article-title":"Patient notification for bloodborne pathogen testing due to unsafe injection practices in the US health care settings, 2001\u20132011","volume":"50","author":"Guh","year":"2012","journal-title":"Med Care"},{"issue":"1 Suppl","key":"2024050816260220100_jiad199-B7","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"2024050816260220100_jiad199-B8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.15585\/mmwr.mm7132e1","article-title":"Vital signs: hepatitis C treatment among insured adults\u2014United States, 2019\u20132020","volume":"71","author":"Thompson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3 Suppl 1","key":"2024050816260220100_jiad199-B9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.510260703","article-title":"Hepatitis C: the clinical spectrum of disease","volume":"26","author":"Hoofnagle","year":"1997","journal-title":"Hepatology"},{"key":"2024050816260220100_jiad199-B10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/jvh.13060","article-title":"Awareness of chronic viral hepatitis in the United States: an update from the National Health and Nutrition Examination Survey","volume":"26","author":"Kim","year":"2019","journal-title":"J Viral Hepat"},{"key":"2024050816260220100_jiad199-B11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement","volume":"323","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"key":"2024050816260220100_jiad199-B12","author":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV","year":"2023"},{"key":"2024050816260220100_jiad199-B13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.kisu.2018.06.001","article-title":"KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"8","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group","year":"2018","journal-title":"Kidney Int Suppl (2011)"},{"issue":"RR-5","key":"2024050816260220100_jiad199-B14","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"2024050816260220100_jiad199-B15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2019.12.016","article-title":"KDOQI US commentary on the 2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C","volume":"75","author":"Roth","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6S","key":"2024050816260220100_jiad199-B16","first-page":"S129","article-title":"KDIGO 2022 Clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group","year":"2022","journal-title":"Kidney Int"},{"key":"2024050816260220100_jiad199-B17","author":"Infectious Diseases Society of America\/American Association for the Study of Liver Diseases"},{"key":"2024050816260220100_jiad199-B18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jama.2022.1246","article-title":"CDC sexually transmitted infections treatment guidelines, 2021","volume":"327","author":"Hazra","year":"2022","journal-title":"JAMA"},{"key":"2024050816260220100_jiad199-B19","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2024050816260220100_jiad199-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6906a1","article-title":"Testing and clinical management of health care personnel potentially exposed to hepatitis C virus\u2014CDC guidance, United States, 2020","volume":"69","author":"Moorman","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2024050816260220100_jiad199-B21","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly"},{"key":"2024050816260220100_jiad199-B22","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.27966","article-title":"Cost-effectiveness of strategies for testing current hepatitis C virus infection","volume":"62","author":"Chapko","year":"2015","journal-title":"Hepatology"},{"key":"2024050816260220100_jiad199-B23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.amepre.2008.10.013","article-title":"Viral RNA testing in hepatitis C antibody\u2013positive veterans","volume":"36","author":"Rongey","year":"2009","journal-title":"Am J Prev Med"},{"key":"2024050816260220100_jiad199-B24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.15585\/mmwr.mm6518a2","article-title":"Identification and clinical management of persons with chronic hepatitis C virus infection\u2014Cherokee nation, 2012\u20132015","volume":"65","author":"Mera","year":"2016","journal-title":"MMWR Morb Mortal Wkly"},{"key":"2024050816260220100_jiad199-B25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cis815","article-title":"Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study","volume":"56","author":"Moorman","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024050816260220100_jiad199-B26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cgh.2019.12.038","article-title":"Hepatitis C care pathway associated with increased screening, confirmation, and diagnosis communication to patients","volume":"19","author":"Rodriguez-Watson","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024050816260220100_jiad199-B27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJM199107113250205","article-title":"A long-term study of hepatitis C virus replication in non-A, non-B hepatitis","volume":"325","author":"Farci","year":"1991","journal-title":"N Engl J Med"},{"key":"2024050816260220100_jiad199-B28","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/ciu695","article-title":"Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men","volume":"59","author":"Vanhommerig","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024050816260220100_jiad199-B29","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States. The sentinel counties chronic non-A, non-B hepatitis study team","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med"},{"key":"2024050816260220100_jiad199-B30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"key":"2024050816260220100_jiad199-B31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/apc.2022.0021","article-title":"Diagnosis and clinical manifestations of acute hepatitis C infection in people living with HIV","volume":"36","author":"O'Shea","year":"2022","journal-title":"AIDS Patient Care STDS"},{"key":"2024050816260220100_jiad199-B32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jamainternmed.2021.5182","article-title":"Seronegative chronic hepatitis C virus infection: a teachable moment","volume":"181","author":"Craft","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2024050816260220100_jiad199-B33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/511038","article-title":"Factors associated with seronegative chronic hepatitis C virus infection in HIV infection","volume":"44","author":"Chamie","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2024050816260220100_jiad199-B34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jceh.2021.05.011","article-title":"Laboratory evaluation of hepatitis C virus infection in patients undergoing hemodialysis from north east India","volume":"12","author":"Kalita","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"2024050816260220100_jiad199-B35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jvh.12994","article-title":"Screening haemodialysis patients for hepatitis C in Vietnam: the inconsistency between common hepatitis C virus serological and virological tests","volume":"26","author":"Duong","year":"2019","journal-title":"J Viral Hepat"},{"issue":"Suppl 2","key":"2024050816260220100_jiad199-B36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/00333549161310S213","article-title":"High-yield birth-cohort hepatitis c virus screening and linkage to care among underserved African Americans, Atlanta, Georgia, 2012\u20132013","volume":"131","author":"Miller","year":"2016","journal-title":"Public Health Rep"},{"key":"2024050816260220100_jiad199-B37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis","volume":"7","author":"Cunningham","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024050816260220100_jiad199-B38","doi-asserted-by":"crossref","first-page":"e2030427","DOI":"10.1001\/jamanetworkopen.2020.30427","article-title":"Evaluation of the Cherokee Nation hepatitis C virus elimination program in the first 22 months of implementation","volume":"3","author":"Mera","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024050816260220100_jiad199-B39","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jamainternmed.2013.8133","article-title":"Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care","volume":"173","author":"Backus","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2024050816260220100_jiad199-B40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3122\/jabfm.2020.03.200105","article-title":"Well-being, new technologies, and clinical evidence for family physicians","volume":"33","author":"Seehusen","year":"2020","journal-title":"J Am Board Fam Med"},{"key":"2024050816260220100_jiad199-B41","doi-asserted-by":"crossref","first-page":"e222427","DOI":"10.1001\/jamanetworkopen.2022.2427","article-title":"Effect of a default order vs an alert in the electronic health record on hepatitis C virus screening among hospitalized patients: a stepped-wedge randomized clinical trial","volume":"5","author":"Mehta","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024050816260220100_jiad199-B42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s11606-019-05536-z","article-title":"Doubling hepatitis C virus screening in primary care using advanced electronic health record tools\u2014a non-randomized controlled trial","volume":"35","author":"Hojat","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2024050816260220100_jiad199-B43","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jvh.13744","article-title":"Hepatitis C active viremia over time in an ED-based testing programme: impact, disparities and surveillance tool","volume":"29","author":"Reynolds","year":"2022","journal-title":"J Viral Hepat"},{"key":"2024050816260220100_jiad199-B44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.5811\/westjem.2021.1.49667","article-title":"Universal screening for hepatitis C virus in the ED using a best practice advisory","volume":"22","author":"Ford","year":"2021","journal-title":"West J Emerg Med"},{"key":"2024050816260220100_jiad199-B45","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/acem.13484","article-title":"Implementation and preliminary results of an emergency department nontargeted, opt-out hepatitis C virus screening program","volume":"25","author":"Schechter-Perkins","year":"2018","journal-title":"Acad Emerg Med"},{"key":"2024050816260220100_jiad199-B46","author":"American College of Obstetricians and Gynecologists","year":"2022"},{"key":"2024050816260220100_jiad199-B47","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Society for Maternal-Fetal Medicine;","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2024050816260220100_jiad199-B48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2019.01.021","article-title":"Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore","volume":"100","author":"Falade-Nwulia","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"2024050816260220100_jiad199-B49","doi-asserted-by":"crossref","first-page":"ofac225","DOI":"10.1093\/ofid\/ofac225","article-title":"Rapid treatment initiation for hepatitis C in young people who inject drugs: the seek, test, and rapid treatment randomized trial","volume":"9","author":"Eckhardt","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024050816260220100_jiad199-B50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamainternmed.2022.0170","article-title":"Accessible hepatitis C care for people who inject drugs: a randomized clinical trial","volume":"182","author":"Eckhardt","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2024050816260220100_jiad199-B51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/003335491412900213","article-title":"Hepatitis C seroprevalence among prison inmates since 2001: still high but declining","volume":"129","author":"Varan","year":"2014","journal-title":"Public Health Rep"},{"key":"2024050816260220100_jiad199-B52","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2468-1253(20)30365-4","article-title":"Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework","volume":"6","author":"Akiyama","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024050816260220100_jiad199-B53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/M16-0065","article-title":"Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis","volume":"165","author":"Freiman","year":"2016","journal-title":"Ann Intern Med"},{"key":"2024050816260220100_jiad199-B54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jhep.2019.02.011","article-title":"Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: analysis of a global dataset","volume":"71","author":"Freiman","year":"2019","journal-title":"J Hepatol"},{"key":"2024050816260220100_jiad199-B55","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/liv.15191","article-title":"Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: a prospective three-arm study","volume":"42","author":"Shilton","year":"2022","journal-title":"Liver Int"},{"key":"2024050816260220100_jiad199-B56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cid\/ciu782","article-title":"Hepatitis C core antigen testing: a reliable, quick, and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection","volume":"60","author":"Cresswell","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024050816260220100_jiad199-B57","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12882-020-02154-4","article-title":"Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients","volume":"21","author":"Wong","year":"2020","journal-title":"BMC Nephrol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad199\/51725737\/jiad199.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/229\/Supplement_3\/S350\/57451599\/jiad199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/229\/Supplement_3\/S350\/57451599\/jiad199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T16:26:48Z","timestamp":1715185608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/229\/Supplement_3\/S350\/7280599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":57,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2023,9,22]]},"published-print":{"date-parts":[[2024,5,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad199","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,15]]},"published":{"date-parts":[[2023,9,22]]}}}